{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Stanford CME | Stanford Medicine
Stanford Center for Continuing Medical Education
  • Sign In
  • Create New Account
  • Home
  • Live Activities
  • On-Demand
  • Hybrid
  • Podcast
  • RSS
  • Journals
  • Other
  • Activity Calendar
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Sign in with your Stanford ID
Sign in with your email and password | Create new account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ADN
  • APRN
  • ASN
  • ASW
  • AT
  • AUD
  • BA
  • BDent
  • BDS
  • BDSc
  • BM BCh
  • BM BS
  • BM ChB
  • BP
  • Bpharm
  • BS
  • BScPH
  • BSN
  • BSPh
  • BSPT
  • BSRT
  • BSW
  • CCP
  • CCT
  • CFRS
  • Chaplain
  • CNL
  • CNM
  • CNM
  • CNS
  • CPhT
  • CRNA
  • CRNP
  • CTR
  • CVT
  • DC
  • DClinDent
  • DDent
  • DDS
  • DDSc
  • DMD
  • DMSc
  • DNE
  • DNP
  • DNSc
  • DO
  • DP
  • DPM
  • DPT
  • DPTSc
  • DrPH
  • DScD
  • DScPT
  • DSW
  • DVM
  • EdD
  • EMT
  • EMT-P
  • FCPS
  • FRCPS
  • JD
  • L.Ac
  • LCPC
  • LCSW
  • LICSW
  • LMFT
  • LMHC
  • LMSW
  • LNM
  • LPC
  • LPCC
  • LPN
  • LRCPE
  • LRCPSG
  • LRCSE
  • LVN
  • MA
  • MB BCH
  • MB Bchir
  • MB BS
  • MB ChB
  • MBA
  • MBBS
  • MCS
  • MD
  • MD, JD
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, PhD
  • MD, MS
  • MD, MSCE
  • MD, PhD
  • MDCM
  • MDent
  • MDentSci
  • MDS
  • MFA
  • MFT
  • MHPE
  • MLIS
  • Mmed
  • MMilMed
  • MMSc
  • MP
  • MPH
  • Mpharm
  • MPT
  • MS
  • MSc
  • MSc, PhD
  • MScPH
  • MScPharm
  • MSD
  • MSM
  • MSN
  • MSN, FNP-BC
  • MSN, PhD
  • MSPH
  • MSPharm
  • MSPT
  • MSSA
  • MSW
  • ND
  • None
  • NP
  • OD
  • OT
  • Other
  • OTR
  • PA
  • PA-C
  • PD
  • Pharm
  • PharmD
  • PharmDc
  • PhD
  • PsyD
  • PT
  • PT, PhD
  • PTA
  • RCES
  • RCP
  • RD
  • RDA
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RTT
  • ScDPT
  • SLP
  • SMF
  • VMD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Stanford Cancer Cell Therapy and Blood and Marrow Transplant Symposium: Update on Current Advances in BMT and Cancer Cell Therapy in honor of Dr. Robert Negrin


Stanford Cancer Cell Therapy and Blood and Marrow Transplant Symposium: Update on Current Advances in BMT and Cancer Cell Therapy in honor of Dr. Robert Negrin Banner

  • Overview
  • Faculty
  • Agenda
  • Location
  • Support
Add to Calendar Stanford Cancer Cell Therapy and Blood and Marrow Transplant Symposium: Update on Current Advances in BMT and Cancer Cell Therapy in honor of Dr. Robert Negrin 4/7/2022 8:00:00 AM 4/8/2022 4:40:00 PM America/Los_Angeles For More Details: https://stanford.cloud-cme.com/BMT2022 Description: The Stanford Cancer Cell Therapy and Blood and Marrow Transplant Symposium will address the current and future state of blood and marrow transplantation and cancer cell therapy to aid participants in their clinical decision making. This hybrid conference offers a review of the latest advances in blood marrow transplantation and cancer cell therapy, including clinical trials research and future approaches on treatment str... Alumni Center false MM/DD/YYYY


Date & Location
Thursday, April 7, 2022, 8:00 AM - Friday, April 8, 2022, 4:40 PM, Alumni Center, Stanford, CA

Overview
The Stanford Cancer Cell Therapy and Blood and Marrow Transplant Symposium will address the current and future state of blood and marrow transplantation and cancer cell therapy to aid participants in their clinical decision making. This hybrid conference offers a review of the latest advances in blood marrow transplantation and cancer cell therapy, including clinical trials research and future approaches on treatment strategies to optimize patients’ clinical outcomes. This year, our symposium will be honoring Dr. Robert Negrin and his years of service as Chief of the Stanford Blood and Marrow Transplantation - Cell Therapy Division. Please join us in recognizing Dr. Negrin’s impactful contributions to the field of Blood and Marrow Transplantation.

Registration
Registration fee includes course materials, certificate of participation, breakfast and lunch.  The symposium is a hybrid activity; you can attend in person or virtually.  Please select the corresponding registration type when registering.

Early Bird Rate: 
Physicians (in person) - $250 
Physicians (virtual) - $250 
Nurses/Allied Health Professionals (in person) - $200 
Nurses/Allied Health Professionals (virtual) - $200

After 3/10/2022
Physicians (in person) - $300 
Physicians (virtual) - $300
Nurses/Allied Health Professionals (in person) - $250 
Nurses/Allied Health Professionals (virtual) - $250

Registration may be paid by Visa, MasterCard or check. If you prefer to pay by phone or check, please contact the Stanford Center for CME at (650) 497-8554 for assistance.

STAP-eligible employees can use STAP funds towards the registration fees for this activity.  Complete the STAP Reimbursement Request Form and submit to your department administrator.

Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently. 

Credits
AMA PRA Category 1 Credits™ (12.50 hours), Non-Physician Participation Credit (12.50 hours)

Target Audience
Specialties - Hematology, Oncology
Professions - Physician

Objectives
At the conclusion of this activity, participants should be able to:

  1. Discuss the importance of stem cell niche in allogeneic hematopoietic cell engraftment.
  2. Examine how to find suitable allogeneic donor(s) for all patients.
  3. Interpret the role of regulatory T cells (Treg) in graft-versus-host disease.
  4. Analyze the novel concept of graft engineering in improving clinical outcomes in allogeneic transplant.
  5. Review the application of cellular therapy in managing autoimmune disease and inducing tolerance.
  6. Review the state-of-art report on the utility of CART cells in B-cell malignancies.
  7. Discuss the development of CART cell therapy in myeloid malignancies.
  8. Examine the utility of CART cell therapy in solid tumor including sarcoma.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Hybrid for a maximum of 12.50 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


Additional Information

Cancellation Policy
Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health


For activity related questions, please contact
     Name: Melissa Schwartz
     Title: Events Project Manager
     Email: [email protected]

For CME general questions, please contact 
 
   Email: [email protected]

Stanford Center for Continuing Medical Education (SCCME) is committed to providing a safe and healthy environment for event attendees and staff members.  SCCME’s decisions and preventive measures will be guided by the requirements and recommendations of Stanford, as well as any federal, state, and local health authorities.  We will continue to monitor the evolving situation and guidelines. 

The responsibility of a safe and healthy environment is shared among SCCME, the venue, and all event attendees.  All attendees are expected to adhere to and abide by the safety measures below, to protect against the spread of COVID-19. 

*Important information for visitors traveling to Stanford Campus, including international visitors: https://healthalerts.stanford.edu/covid-19/visitors/

Conference Location
Frances C. Arrillaga Alumni Center
326 Galvez Street 
Stanford, CA
Phone: 650-723-2021

Nearby Hotels
View hotel options by visiting: www.destinationpaloalto.com/lodging 

Visiting Stanford
To learn more about traveling to Stanford University, please browse visit.stanford.edu.



Mitigation of Relevant Financial Relationships


Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity, except for:



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Wen-Kai Weng, MD, PhD
Associate Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Co-Course Director, Faculty
Nothing to disclose
Laura Jean Johnston, MD
Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Course Director, Faculty
Nothing to disclose
Frederick R Appelbaum, MD
Professor, Metcalfe Family Endowed Chair in Cancer Research
Fred Hutchinson Comprehensive Cancer Center
Faculty
Paid consultant-Jasper Therapeutics|Ownership-Jasper Biotherapy|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Rubius Therapeutics
Sally Arai, MD
Associate Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Faculty
Advisor-Kadmon
Andreas Beilhack, MD
Professor of Medicine and Pediatrics, Head of Interdisciplinary Center for Clinical Research Laboratory for Experimental Stem Cell Transplantation
Wurzburg University
Germany
Faculty
Royalties or Patent Beneficiary-Aamuthera Biotech GmBH |Royalties or Patent Beneficiary-DualYX NV|Consulting Fee-Roche
Alice Bertaina, Other
Lorry I. Lokey Professor of Pediatrics
Section Chief, Stem Cell Transplant and Regenerative Medicine
Medical Director of Inpatient Services, Lucile Packard Children's Hospital
Co-Director, Bass Center for Childhood Cancer and Blood Diseases, Lucile Packard Children's Hospital
Division of Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine
Stanford University School of Medicine
Faculty
Nothing to disclose
Matthias Edinger, MD, PhD
Professor
Head of Stem Cell Transplant and Cellular Therapy Program
Department of Internal Medicine III, University Hospital Regensburg & Leibniz Institute for Immunotherapy
Germany
Faculty
Nothing to disclose
Edgar Engleman, MD
Professor of Pathology
Stanford University School of Medicine
Faculty
Royalties or Patent Beneficiary-Bolt Bio|Advisor-Ossium|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Medeor|Advisor-ImmunEdge|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Tranquis|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Vivo Capital
Steve Feldman, PhD
Site Head and Scientific Director, Laboratory for Cell and Gene Medicine
Stanford University School of Medicine
Faculty
Advisor-KITE Pharma (Relationship has ended)|Paid consultant-TCG Crossover (Relationship has ended)|Paid consultant-Vida Ventures (Relationship has ended)|Grant or research support-Lonza PerMed (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Fresh Wind Bio|Grant or research support-Syncopation
Stephen Forman, MD
Professor, Director of Hematologic Malignancies Research Institute
City of Hope Comprehensive Cancer Center
Faculty
Grant or research support-Mustang Bio|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lixte Bio
Matthew Joshua Frank, MD, PhD
Assistant Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Faculty
Nothing to disclose
Saar Gill, MD, PhD
Associate Professor of Medicine
University of Pennsylvania, Perelman School of Medicine
Faculty
Consulting Fee-Carisma Therapeutics|Consulting Fee-Interius Biotherapeutics|Advisor-ImmPact Bio|Grant or research support-Carisma Therapeutics|Grant or research support-Interius Biotherapeutics|Stocks or stock options, excluding diversified mutual funds-Carisma Therapeutics|Stocks or stock options, excluding diversified mutual funds-Interius Biotherapeutics|Grant or research support-Asher Bio|Grant or research support-Hemogenyx, LLC
Robert Lowsky, MD
Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Faculty
Nothing to disclose
Peggy Lu, MD
Director of Hematology and Oncology
Medical Executive President
Lu Daopei Hospital
China
Faculty
Nothing to disclose
Crystal Lee Mackall, MD
Professor of Pediatrics (Hematology/Oncology) and of Medicine
Stanford University School of Medicine
Faculty
Grant or research support-Lyell Immunopharma|Consulting Fee-Lyell Immunopharma|Ownership-Lyell Immunopharma|Consulting Fee-Syncopation Life Sciences|Ownership-Syncopation Life Sciences|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Syncopation Life Sciences|Ownership-Link Cell Therapies|Advisor-Bristol-Myers Squibb (Relationship has ended)|Advisor-Nektar|Advisor-Glaxo Smith Kline|Consulting Fee-Immatics|Consulting Fee-Neoimmune Tech|Advisor-Apricity|Advisor-Ensoma|Ownership-Ensoma
Everett Meyer, MD
Associate Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Faculty
Grant or research support-Orca Biosystem|Consulting Fee-Indee|Ownership-Triursus Therapeutics|Stocks or stock options, excluding diversified mutual funds-Jura|Consulting Fee-CTI (Relationship has ended)
David Miklos, MD, PhD
Division Chief, Professor of Medicine (Blood and Marrow Transplantation)
SHC - Cancer Center
Faculty
Advisor-Kte - Gilead|Grant or research support-Kite - Gilead|Consulting Fee-Adaptive Bioptechnologies|Grant or research support-Allogene
Lori Muffly, MD
Associate Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Faculty
Advisor-Kite|Advisor-CTI Biopharma (Relationship has ended)|Advisor-Amgen (Relationship has ended)|Paid consultant-Astellas|Grant or research support-BMS|Grant or research support-Jasper|Grant or research support-Kite|Honoraria-Adaptive|Grant or research support-Adaptive
Robert Stuart Negrin, MD
Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Faculty
Nothing to disclose
Andrew Rezvani, MD
Assistant Professor of Medicine (Blood and Marrow Transplantation)
SHC - Cancer Center
Faculty
Grant or research support-Pharmacyclics
Maria-Grazia Roncarolo, MD
Professor
Stanford University
Faculty
Nothing to disclose
Liora Michal Schultz, MD
Assistant Professor of Pediatrics
Stanford University School of Medicine
Faculty
Advisor-Novartis AG
Judith Shizuru, MD, PhD
Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Jasper Therapeutics, Inc|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Shoreline Biosciences|Membership on Advisory Committees or Review Panels, Board Membership, etc.-rBio
Surbhi Sidana, MD
Assistant Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Faculty
Grant or research support-Bristol-Myers Squibb|Grant or research support-Johnson and Johnson|Grant or research support-Allogene, Magenta Therapeutics|Consulting Fee-Magenta Therapeutics, BMS, Janssen, Sanofi, Oncopeptides
Melody Smith, MD
Assistant Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine
Faculty
Nothing to disclose
Michael R Verneris, MD, PhD
Professor of Pediatrics
Director of Transplantation and Cellular Therapy
University of Colorado
Faculty
Honoraria-Novartis AG (Relationship has ended)|Honoraria-Medexus (Relationship has ended)|Honoraria-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Honoraria-Equillium (Relationship has ended)|Advisor-Artisan|Advisor-Terumo
Robert Zeiser, MD
Professor, Head of Tumor Immunology and Immune Modulation
University of Freiburg
Germany
Faculty
Consulting Fee-Novartis AG (Relationship has ended)|Consulting Fee-Mallinckrodt, Inc. (Relationship has ended)

Thursday, April 7, 2022
Registration and Breakfast
8:00AM - 8:40AM
Introductory Remarks
8:40AM - 8:50AM
Laura Jean Johnston, MD
Wen-Kai Weng, MD, PhD
Tribute from The Stanford Cancer Institute (No CME)
8:50AM - 9:00AM

Beverly Mitchell, MD
How We Got Here
9:00AM - 9:30AM
Frederick R Appelbaum, MD
Translation from The Mouse Model to Clinical Practice
9:30AM - 10:00AM
Robert Zeiser, MD
Targeting the Stem Cell Niche with Antibody: The Science and The Application
10:00AM - 10:30AM
Judith Shizuru, MD, PhD
Will Everyone Have a Suitable Donor
10:30AM - 11:00AM
Andrew Rezvani, MD
Break
11:00AM - 11:15AM
Treg in Allogeneic SCT: A Personal View
11:15AM - 11:45AM
Matthias Edinger, MD, PhD
Regulation of Intestinal Acute VHD
11:45AM - 12:15PM
Andreas Beilhack, MD
Modern Day Graft Manipulation: The Stanford Experience
12:15PM - 12:45PM
Everett Meyer, MD
Lunch
12:45PM - 1:30PM
Tribute from Hospital Leadership (No CME)
1:30PM - 1:40PM

Sridhar Seshadri, PhD
Autologous Transplant in Autoimmune Disease
1:40PM - 2:10PM
Sally Arai, MD
Recent Progress for CAR T Cells for Solid Tumors
2:10PM - 2:40PM
Crystal Lee Mackall, MD
ab T-cell Depleted Haploidentical HSCT: A New Platform for Immunotherapy
2:40PM - 3:10PM
Alice Bertaina, Other
Break
3:10PM - 3:25PM
Minimal Residual Disease (MRD) in The Management of ALL
3:25PM - 3:55PM
Lori Muffly, MD
Cell Therapy with Type 1 Regulatory T Cells in Hematopoietic Cell Transplantation
3:55PM - 4:25PM
Maria-Grazia Roncarolo, MD
Tribute from Patients I (No CME)
4:25PM - 4:45PM

Introduction by Kathryn Tierney, PhD, RN
Friday, April 8, 2022
Registration and Breakfast
8:00AM - 8:25AM
Welcome & Announcements
8:25AM - 8:30AM
Laura Jean Johnston, MD
Wen-Kai Weng, MD, PhD
Invariant Natural Killer T Cells in Transplantation - A Double Edge Sword
8:30AM - 9:00AM
Robert Stuart Negrin, MD
Immunotherapy for Cancer
9:00AM - 9:30AM
Edgar Engleman, MD
CAR T Cells for B-Cell Lymphoma
9:30AM - 10:00AM
David Miklos, MD, PhD
Liquid Biopsy as an Adjunct to CAR T Cell Therapy
10:00AM - 10:30AM
Matthew Joshua Frank, MD, PhD
Break
10:30AM - 10:45AM
CAR T Cells for Pediatric B-ALL: State-of-the-Art
10:45AM - 11:15AM
Liora Michal Schultz, MD
Incorporating CAR T Cell Therapy in the Management of Myeloma
11:15AM - 11:45AM
Surbhi Sidana, MD
CAR T Therapy in China: Experience from Lu Daopei Hospital
11:45AM - 12:15PM
Peggy Lu, MD
Lunch
12:15PM - 1:00PM
Tribute From Patients, II (No CME)
1:00PM - 1:20PM

Introduction by Kathryn Tierney, PhD, RN
CAR T Cells for Myeloid Malignancies
1:20PM - 1:50PM
Saar Gill, MD, PhD
CAR T Cells for Sarcoma
1:50PM - 2:20PM
Michael R Verneris, MD, PhD
Is There a Role for CAR T Cells in HCT?
2:20PM - 2:50PM
Stephen Forman, MD
Break
2:50PM - 3:00PM
Incorporating CAR T into Allogeneic Transplant
3:00PM - 3:30PM
Melody Smith, MD
GMP Manufacturing: Current Concepts and a Look Toward the Future
3:30PM - 4:00PM
Steve Feldman, PhD
Use of Hematopoietic Cell Transplantation to Induce Tolerance to Organ Transplants
4:00PM - 4:30PM
Robert Lowsky, MD

In Memory of Samuel Strober, Presented by Robert Lowsky, MD
Closing Remarks
4:30PM - 4:40PM
David Miklos, MD, PhD

This CME activity is supported in part by educational grants from Adaptive Biotechnologies, Celgene, Kite, a Gilead Company, Mallinckrodt Pharmaceuticals, Novartis, Orca biosystems & Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Thank you to our sponsor Allogene.

 

©2023 Stanford Medicine | Privacy Policy | Terms of Use

Contact Us: [email protected]

StanfordCME Facebook StanfordCME Twitter StanfordCME Podcast StanfordCME LinkedIn StanfordCME Youtube